What's in Jesús Moreno Fernández's pipeline?

Jesús Moreno Fernández has 1 drugs in our index: 0 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Jesús Moreno Fernández's portfolio?

Top competitors by shared drug class: Boston Medical Center, Eli Lilly and Company, Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud, Geropharm, Mountain Diabetes and Endocrine Center.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/jes-s-moreno-fern-ndez.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Jesús Moreno Fernández — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Jesús Moreno Fernández pipeline: 0 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Diabetes · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Boston Medical Center · 1 shared drug class
Eli Lilly and Company · 1 shared drug class
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud · 1 shared drug class
Geropharm · 1 shared drug class
Mountain Diabetes and Endocrine Center · 1 shared drug class
Mylan Inc. · 1 shared drug class
Nanjing First Hospital, Nanjing Medical University · 1 shared drug class
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Jesús Moreno Fernández:

Cite this brief

Drug Landscape (2026). Jesús Moreno Fernández — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/jes-s-moreno-fern-ndez. Accessed 2026-05-17.